Understanding Myeloma | How You Can Collaborate in Your Care
https://vimeo.com/942111089 This animated video reviews the types of myeloma, essential testing following a myeloma diagnosis, and advice for working with your healthcare team for the best overall care. See More…
How Can Bispecific Antibody Therapy Care Partners Be Proactive?
https://vimeo.com/940909348 What are some ways for myeloma bispecific antibody therapy care partners to be proactive? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute shares lifestyle modifications, reasons to speak up…
Bispecific Antibody Therapy Support | Care Team Members and Resources
https://vimeo.com/940909300 What should myeloma patients know about bispecific antibody therapy support? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute discusses care team members and support resources for bispecific antibody therapy…
What Is the Role of a Care Partner in Bispecific Antibody Therapy?
https://vimeo.com/940909265 How can a myeloma care partner support a bispecific antibody therapy patient? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute explains ways that care partners can offer logistical and…
Bispecific Antibody Therapy | What Is the Treatment Duration and Response?
https://vimeo.com/940909235 What can myeloma bispecific antibody therapy patients expect for treatment duration and response? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute discusses treatment factors that may impact response, common…
Bispecific Antibody Therapy | Managing Side Effects
https://vimeo.com/940909187?fl=pl&fe=sh What should myeloma bispecific antibody therapy patients know about managing side effects? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute discusses common short-term and long-term side effects, members of…
How Is Bispecific Antibody Therapy Administered?
https://vimeo.com/940909156 How is myeloma bispecific antibody therapy given to patients? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute explains how the treatment is administered in the body, hospital types to…
Bispecific Antibodies for Myeloma | Patient Eligibility Requirements
https://vimeo.com/940909113 What are the myeloma patient eligibility requirements for bispecific antibodies? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer Institute discusses patient types that work well with bispecific antibody therapy, patient…
How Has Bispecific Antibody Therapy Impacted Myeloma Care?
Understanding Myeloma Therapy Targets BCMA and GPRC5D
https://vimeo.com/936716579 What are myeloma targets, and how do they impact the effectiveness of therapy? Dr. Krina Patel explains how treatments like bispecific antibodies and CAR T-cell therapy are using myeloma…
How Is CAR T-Cell Therapy Research Advancing Myeloma Care?
https://vimeo.com/936716514 What progress is being made in furthering advancing CAR T-cell therapy for myeloma? Dr. Krina Patel discusses the manufacturing process for CAR T-cells, research updates for manufacturing CAR T-cells…
How Can Myeloma Patients Access CAR T-Cell Therapy Clinical Trials?
https://vimeo.com/936716464 How can patients learn more about joining myeloma CAR T-cell therapy clinical trials? Dr. Krina Patel shares advice for identify and accessing these trials, noting that seeking care with…